Search results for "tumor cell"

showing 10 items of 694 documents

ChemInform Abstract: Carbohydrate Nanocarriers in Biomedical Applications: Functionalization and Construction

2015

The specific targeting of either tumor cells or immune cells in vivo by carefully designed and appropriately surface-functionalized nanocarriers may become an effective therapeutic treatment for a variety of diseases. Carbohydrates, which are prominent biomolecules, have shown their outstanding ability in balancing the biocompatibility, stability, biodegradability, and functionality of nanocarriers. The recent applications of sugar (mono/oligosaccharides and/or polysaccharides) for the development of nanomedicines are summarized in this review, including the application of carbohydrates for the surface-functionalization of various nanocarriers and for the construction of the nanocarrier its…

chemistry.chemical_classificationBiocompatibilitychemistryBiomoleculeTherapeutic treatmentSurface modificationNanotechnologyTumor cellsGeneral MedicineNanocarriersChemInform
researchProduct

Posttranslational processing of human alpha 2-HS glycoprotein (human fetuin). Evidence for the production of a phosphorylated single-chain form by he…

1994

alpha 2-HS glycoprotein (alpha 2-HS) is a major protein occurring in human blood and calciferous tissues. Due to extensive sequence identity, alpha 2-HS has been grouped with the fetuins, a family of proteins that occur in fetal plasma in high concentrations. Native alpha 2-HS undergoes a series of posttranslational modifications including proteolytic processing, multiple N-glycosylations and O-glycosylations, and sulfation of the carbohydrate side chains. Various two-chain forms of alpha 2-HS have been prepared from human plasma, however, the single-chain precursor has not yet been isolated. Here, we have studied the biosynthesis of alpha 2-HS by a human hepatoma cell line, HepG2. We demon…

chemistry.chemical_classificationCarcinoma HepatocellularGlycosylationLiver NeoplasmsMolecular Sequence DataAlpha (ethology)PeptideBiologyBiochemistryFetuinSerineSulfationchemistryBiochemistryTumor Cells CulturedPhosphorylationHumansAmino Acid Sequencealpha-FetoproteinsPhosphorylationGlycoproteinPeptide sequenceProtein Processing Post-TranslationalEuropean journal of biochemistry
researchProduct

Carbohydrate nanocarriers in biomedical applications: functionalization and construction

2015

The specific targeting of either tumor cells or immune cells in vivo by carefully designed and appropriately surface-functionalized nanocarriers may become an effective therapeutic treatment for a variety of diseases. Carbohydrates, which are prominent biomolecules, have shown their outstanding ability in balancing the biocompatibility, stability, biodegradability, and functionality of nanocarriers. The recent applications of sugar (mono/oligosaccharides and/or polysaccharides) for the development of nanomedicines are summarized in this review, including the application of carbohydrates for the surface-functionalization of various nanocarriers and for the construction of the nanocarrier its…

chemistry.chemical_classificationDrug CarriersBiomedical ResearchBiocompatibilitySurface PropertiesBiomoleculeTherapeutic treatmentCarbohydratesBiocompatible MaterialsNanotechnologyTumor cellsGeneral ChemistryBiocompatible materialNanostructureschemistryAnimalsHumansSurface modificationNanocarriersDrug carrier
researchProduct

The Creolophins: A Family of Linear Triquinanes fromCreolophus cirrhatus (Basidiomycete)

2007

Complicatic acid and five novel linear triquinanes were isolated from mycelial cultures of Creolophus cirrhatus. The creolophins A, C, D, and E represent a novel type of highly oxidized triquinane sesquiterpenoids. Whereas those compounds with a secondary alcohol moiety in ring A are stable, the exomethylene ketone creolophin E (5) partly dimerized during workup to form the decacyclic 1,4-dioxepin-6-one neocreolophin (6). Compounds 5 and 6 display cytotoxic activities against several tumor cell lines.(© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2007)

chemistry.chemical_classificationKetoneStereochemistryOrganic ChemistryAlcoholTumor cellsNuclear magnetic resonance spectroscopyRing (chemistry)Terpenoidchemistry.chemical_compoundchemistryCreolophus cirrhatusMoietyPhysical and Theoretical ChemistryEuropean Journal of Organic Chemistry
researchProduct

Corrigendum to “Effects of Oleuropein on tumor cell growth and bone remodeling: Potential clinical implications for the prevention and treatment of m…

2021

chemistry.chemical_compoundText miningchemistrybusiness.industryOleuropeinCancer researchMedicineTumor cellsGeneral MedicineGeneral Pharmacology Toxicology and PharmaceuticsbusinessGeneral Biochemistry Genetics and Molecular BiologyBone remodelingLife Sciences
researchProduct

Integrin α2β1 Mediates Isoform-Specific Activation of p38 and Upregulation of Collagen Gene Transcription by a Mechanism Involving the α2 Cytoplasmic…

1999

Two collagen receptors, integrins alpha1beta1 and alpha2beta1, can regulate distinct functions in cells. Ligation of alpha1beta1, unlike alpha2beta1, has been shown to result in recruitment of Shc and activation of the Ras/ERK pathway. To identify the downstream signaling molecules activated by alpha2beta1 integrin, we have overexpressed wild-type alpha2, or chimeric alpha2 subunit with alpha1 integrin cytoplasmic domain in human osteosarcoma cells (Saos-2) lacking endogenous alpha2beta1. The chimeric alpha2/alpha1 chain formed a functional heterodimer with beta1. In contrast to alpha2/alpha1 chimera, forced expression of alpha2 integrin resulted in upregulation of alpha1 (I) collagen gene …

collagenIntegrinsReceptors CollagenTranscription GeneticintegrinIntegrincytoplasmic domainCDC42Biologyp38 MAPKTransfectionCD49cp38 Mitogen-Activated Protein KinasesCollagen receptorTumor Cells CulturedHumansProtein IsoformsCell BiologyMolecular biologyCell biologyUp-RegulationEnzyme ActivationIntegrin alpha Mbiology.proteinIntegrin beta 6Original ArticleSignal transductionMitogen-Activated Protein KinasesITGA6Signal TransductionThe Journal of Cell Biology
researchProduct

WRN protects against topo I but not topo II inhibitors by preventing DNA break formation

2008

The Werner syndrome helicase/3′-exonuclease (WRN) is a major component of the DNA repair and replication machinery. To analyze whether WRN is involved in the repair of topoisomerase-induced DNA damage we utilized U2-OS cells, in which WRN is stably down-regulated (wrn-kd), and the corresponding wild-type cells (wrn-wt). We show that cells not expressing WRN are hypersensitive to the toxic effect of the topoisomerase I inhibitor topotecan, but not to the topoisomerase II inhibitor etoposide. This was shown by mass survival assays, colony formation and induction of apoptosis. Upon topotecan treatment WRN deficient cells showed enhanced DNA replication inhibition and S-phase arrest, whereas af…

congenital hereditary and neonatal diseases and abnormalitiesWerner Syndrome HelicaseDNA RepairCell SurvivalDNA damageDNA repairBlotting WesternApoptosisBone NeoplasmsBiologyTopoisomerase-I InhibitorBiochemistryArticleWerner Syndrome HelicaseColony-Forming Units AssayHistonesTumor Cells CulturedmedicineHumansTopoisomerase II InhibitorsEnzyme InhibitorsRNA Small InterferingeducationMolecular BiologyEtoposideOsteosarcomaeducation.field_of_studyRecQ HelicasesTopoisomeraseCell CycleDNA Breaksnutritional and metabolic diseasesCell BiologyAntineoplastic Agents PhytogenicMolecular biologyDNA Topoisomerases Type IIExodeoxyribonucleasesBromodeoxyuridineDNA Topoisomerases Type IDNA Replication InhibitionCancer researchbiology.proteinTopoisomerase I InhibitorsTopoisomerase-II InhibitorTopotecanCamptothecinmedicine.drugDNA Repair
researchProduct

Targeting DNA double strand break repair with hyperthermia and DNA-PKcs inhibition to enhance the effect of radiation treatment

2016

// Bregje van Oorschot 1 , Giovanna Granata 1 , Simone Di Franco 2 , Rosemarie ten Cate 1 , Hans M. Rodermond 1 , Matilde Todaro 3 , Jan Paul Medema 1 , Nicolaas A.P. Franken 1 1 Laboratory for Experimental Oncology and Radiobiology (LEXOR), Center for Experimental Molecular Medicine, Department of Radiation Oncology, Academic Medical Center, Cancer Genomics Center, Amsterdam, The Netherlands 2 Department of Surgical, Oncological and Stomatological Sciences (DICHIRONS), Cellular and Molecular Pathophysiology Laboratory, University of Palermo, Palermo, Italy 3 Biomedical Department of Internal and Specialistic Medicine (DIBIMIS), University of Palermo, Palermo, Italy Correspondence to: Nicol…

double-strand break0301 basic medicineRadiation-Sensitizing AgentsPathologymedicine.medical_specialtyDNA End-Joining RepairRadiobiologyDNA repairDNA damageMorpholinesmedicine.medical_treatmentMice NudeUterine Cervical NeoplasmsDNA repairBreast NeoplasmsDNA-Activated Protein KinaseRadiation ToleranceMice03 medical and health sciences0302 clinical medicineCancer stem cellTumor Cells CulturedAnimalsHumansMedicineDNA Breaks Double-StrandedHomologous RecombinationDNA-PKcsdouble-strand breaksRadiotherapybusiness.industryCancerradiation oncologyHyperthermia Inducedhyperthermiamedicine.diseaseRadiation therapyradiation oncology.030104 developmental biologyOncologyChromones030220 oncology & carcinogenesisCancer cellNeoplastic Stem CellsCancer researchFemalebusinessResearch PaperDNA DamageOncotarget
researchProduct

Annexin-1 downregulation in thyroid cancer correlates to the degree of tumour differentiation

2006

We investigated the expression of annexin-1 (ANXA1) in thyroid carcinoma cell lines and in thyroid cancers with a different degree of differentiation. The highest level of ANXA1 expression examined by Western blotting was detected in the papillary carcinoma cells (NPA) and in the follicular cells (WRO). On the other hand, the most undifferentiated thyroid carcinoma cells (ARO and FRO) presented the lowest level of ANXA1 expression. In surgical tissue specimens from 32 patients with thyroid cancers, we found high immunoreactivity for ANXA1 in papillary (PTC) and follicular (FTC) thyroid cancers while in undifferentiated thyroid cancers (UTC) the expression of the protein was barely detectabl…

endocrine systemCancer ResearchPathologymedicine.medical_specialtyannexin-1endocrine system diseasesCellular differentiationThyroid Glandmedicine.disease_causeThyroid carcinomaDownregulation and upregulationannexinopathieTumor Cells CulturedmedicineHumansThyroid Neoplasmsdifferentiation markerThyroid cancerThyroid NeoplasmAnnexin A1PharmacologyRegulation of gene expressionbusiness.industryThyroidCell Differentiationmedicine.diseaseapoptosithyroid carcinomaGene Expression Regulation Neoplasticmedicine.anatomical_structureOncologyCell cultureMolecular MedicineCarcinogenesisbusinessHumanCancer Biology & Therapy
researchProduct

Shedding of extracellular membrane vesicles from both normal and tumor cells in culture

2009

Tumor cells of different origins shed extracellular membrane vesicles (MVs), that contain angiogenetic- and pro-apoptotic-factors as well as matrix metalloproteases (MMPs). In addition, also neurons and astrocytes in culture produce VEGF- and FGF2- containing MVs, while oligodendroglioma (G26/24) cells release FasL-containing MVs that inhibit neurite sprouting and cause neuronal apoptosis. Starting from these observations, we have been analyzing composition of MVs produced by both normal and tumor cells in culture. We found that MVs from G26/24 cells contain TRAIL, Hsp70, and VEGF. We also traced the route of shed MVs, by adding vesicles that contain 35S-labeled proteins to unlabeled neuron…

extracellular membrane vesicles tumor cells neurons
researchProduct